COLCHICINE REDUCES MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Fadhil, Ameer
Al Wssawi, Abbas
Gumera, Armand
Hashim, Hashim Talib
Al-Shammari, Ali Saad
Abdeltawwab, Mohannad
Amin, Mahmoud
机构：
[1] Univ Warith Al Anbyiaa, Coll Med, Karbala, Iraq
[2] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229-164
引用
收藏
页码：919 / 919
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Shuo
    Gao, Weihua
    Li, Haixia
    Zou, Meijuan
    Sun, Sihao
    Ba, Yijie
    Liu, Yang
    Cheng, Gang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 87 - 95
  • [22] Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
    Deng, Chang-Jiang
    Yan, Ju
    Zheng, Ying-Ying
    Wu, Ting-Ting
    Pan, Ying
    Hou, Xian-Geng
    Wang, Si-Fan
    Sirajidin, Subinur
    Aimaitijiang, Mikereyi
    Xie, Xiang
    BMJ OPEN, 2023, 13 (11):
  • [23] Percutaneous coronary intervention facilitated by fibrinolytics: a meta-analysis of randomized controlled trials
    Afilalo, J.
    Roy, A. M.
    Eisenberg, M. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 599 - 599
  • [24] Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention: a meta-analysis of cohort studies
    Zhang, Chunyu
    Li, Minghao
    Liu, Lin
    Deng, Li
    Yulei, Xie
    Zhong, Yi
    Liao, Bin
    Yu, Lu
    Feng, Jian
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01)
  • [25] Systemic immune-inflammation index as a novel predictor of major adverse cardiovascular events in patients undergoing percutaneous coronary intervention: a meta-analysis of cohort studies
    Chunyu Zhang
    Minghao Li
    Lin Liu
    Li Deng
    Xie Yulei
    Yi Zhong
    Bin Liao
    Lu Yu
    Jian Feng
    BMC Cardiovascular Disorders, 24
  • [26] Is Aspiration Thrombectomy Beneficial in Patients Undergoing Primary Percutaneous Coronary Intervention? Meta-Analysis of Randomized Trials
    Elgendy, Islam Y.
    Huo, Tianyao
    Bhatt, Deepak L.
    Bavry, Anthony A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (07)
  • [27] Tailored anti-platelet treatment guided by the platelet function assays reduces the major cardiac events in patients undergoing percutaneous coronary intervention: a meta- analysis of randomized controlled trials
    Lei, Xu
    Li, Chunjian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C140 - C140
  • [28] ODDS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH VARENICLINE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Singh, Sonal
    Loke, Yoon Kong
    Spangler, John
    Furberg, Curt D.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S290 - S290
  • [29] Efficacy and Safety of Shortened Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Hui, Jiaojiao
    Bai, Ting
    Liang, Le
    He, Qingqing
    Tian, Nani
    Li, Xiao
    Yang, Rui
    Zhu, Lin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (05) : 700 - 708
  • [30] Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Hongtao Lu
    Wenjun Guan
    Yanhua Zhou
    Zhangui Tang
    Hong Bao
    Diabetes Therapy, 2019, 10 : 937 - 950
12345